BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11457465)

  • 1. Antiplatelet and anticoagulant effects of "HN-11 500," a selective thromboxane receptor antagonist.
    Schenk JF; Radziwon P; Fellier H; Breddin HK
    Thromb Res; 2001 Jul; 103(2):79-91. PubMed ID: 11457465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
    Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
    Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests.
    Krupiński K; Ferber H; Breddin HK; Bielawiec M
    Acta Haematol Pol; 1994; 25(3):235-42. PubMed ID: 7992596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
    Kawano KI; Hokamura K; Kondo K; Ikeda Y; Suzuki Y; Umemura K
    Eur J Pharmacol; 2001 Apr; 417(3):217-22. PubMed ID: 11334853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.
    Kuo HL; Lien JC; Chung CH; Chang CH; Lo SC; Tsai IC; Peng HC; Kuo SC; Huang TF
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):495-505. PubMed ID: 20349046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
    Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
    Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.
    Schenk JF; Glusa E; Radziwon P; Butti A; Markwardt F; Breddin HK
    Haemostasis; 1996; 26(4):187-94. PubMed ID: 8872129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium.
    Lau AJ; Toh DF; Chua TK; Pang YK; Woo SO; Koh HL
    J Ethnopharmacol; 2009 Sep; 125(3):380-6. PubMed ID: 19665534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of a new thromboxane receptor antagonist (Z-335) after single and multiple oral administrations to healthy volunteers.
    Matsuno H; Uematsu T; Niwa M; Kozawa O; Nagashima S; Kohno K; Kato H; Kawabata Y; Yoshida Y; Kanamaru M
    J Clin Pharmacol; 2002 Jul; 42(7):782-90. PubMed ID: 12092745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in man.
    Ritter JM; Benjamin N; Doktor HS; Barrow SE; Mant TG; Schey S; Stewart-Long P
    Br J Clin Pharmacol; 1990 Apr; 29(4):431-6. PubMed ID: 2139338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
    Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
    Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.
    Yoo H; Ku SK; Lee W; Kwak S; Baek YD; Min BW; Jeong GS; Bae JS
    Arch Pharm Res; 2014 Aug; 37(8):1069-78. PubMed ID: 24234914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a new thromboxane A2 receptor antagonist, S-1452, and its effect on platelet aggregation in healthy volunteers.
    Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T
    J Clin Pharmacol; 1996 May; 36(5):409-13. PubMed ID: 8739019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.
    Tanaka T; Fukuta Y; Higashino R; Sato R; Nomura Y; Fukuda Y; Ito S; Takei M; Kurimoto T; Tamaki H
    Eur J Pharmacol; 1998 Sep; 357(1):53-60. PubMed ID: 9788773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polysulfonate derivative (GL 522-Y-1) on coagulation in vitro and thrombosis in vivo.
    Radziwon P; Boczkowska-Radziwon B; Giedrojc J; Schenk J; Wojtukiewicz MZ; Kloczko J; Breddin HK
    Haemostasis; 1998; 28(2):86-92. PubMed ID: 10087433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation.
    Richardson A; Sakariassen KS; Meyer JP; Alberts P; Sorensen AS
    Eur J Clin Pharmacol; 2013 Mar; 69(3):459-65. PubMed ID: 22815050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers.
    Reilly MP; Moran N; Meagher E; Delanty N; Cucchiara AE; Lawson JA; Catella-Lawson F
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):12-8. PubMed ID: 9890391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.